NO970258D0 - Dobbelt hybrid system - Google Patents

Dobbelt hybrid system

Info

Publication number
NO970258D0
NO970258D0 NO970258A NO970258A NO970258D0 NO 970258 D0 NO970258 D0 NO 970258D0 NO 970258 A NO970258 A NO 970258A NO 970258 A NO970258 A NO 970258A NO 970258 D0 NO970258 D0 NO 970258D0
Authority
NO
Norway
Prior art keywords
hybrid system
double hybrid
double
hybrid
Prior art date
Application number
NO970258A
Other languages
English (en)
Other versions
NO970258L (no
Inventor
Bhabatosh Chaudhuri
Christine Stephan
Peter Fuerst
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of NO970258D0 publication Critical patent/NO970258D0/no
Publication of NO970258L publication Critical patent/NO970258L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/16Hydrolases (3) acting on ester bonds (3.1)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034Isolating an individual clone by screening libraries
    • C12N15/1055Protein x Protein interaction, e.g. two hybrid selection
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/12Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6897Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
NO970258A 1994-07-22 1997-01-21 Dobbelt hybrid system NO970258L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP94810435 1994-07-22
PCT/EP1995/002724 WO1996003501A1 (en) 1994-07-22 1995-07-12 Dual hybrid system

Publications (2)

Publication Number Publication Date
NO970258D0 true NO970258D0 (no) 1997-01-21
NO970258L NO970258L (no) 1997-03-03

Family

ID=8218290

Family Applications (1)

Application Number Title Priority Date Filing Date
NO970258A NO970258L (no) 1994-07-22 1997-01-21 Dobbelt hybrid system

Country Status (6)

Country Link
EP (1) EP0775206A1 (no)
JP (1) JPH11506301A (no)
AU (1) AU2983295A (no)
FI (1) FI970205A (no)
NO (1) NO970258L (no)
WO (1) WO1996003501A1 (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ306767A (en) * 1995-04-11 2000-03-27 Univ Johns Hopkins Method of identifying molecular interactions employing counterselection and at least two hybrid molecules or two hybrid systems
EP0882128A1 (en) * 1996-02-23 1998-12-09 Ariad Pharmaceuticals, Inc. Cell-based assay
AU4596597A (en) * 1996-09-27 1998-04-17 Icos Corporation Method to identify compounds for disrupting protein/protein interactions
US6093565A (en) * 1996-12-12 2000-07-25 Incyte Pharmaceuticals, Inc. Protein phosphatase regulatory subunit
WO1998046796A1 (en) * 1997-04-11 1998-10-22 The Regents Of The University Of California A method of screening nucleotide sequences to identify disruptors or effectors of biological processes or pathways
EP1632207B1 (en) 2001-07-26 2012-08-29 The Procter & Gamble Company Absorbent articles with elastic topsheets
EP1417945B1 (en) 2002-11-08 2008-12-31 The Procter & Gamble Company Disposable absorbent articles with masking topsheet
DE60333368D1 (de) 2003-10-02 2010-08-26 Procter & Gamble Absorbierender Artikel mit elastomerischem Material
EP1776939A1 (en) 2005-10-18 2007-04-25 The Procter and Gamble Company Absorbent Articles with comfortable Elasticated Laminates
EP1787609A1 (en) 2005-10-18 2007-05-23 The Procter and Gamble Company Absorbent Articles with Comfortable Elasticated Laminates
ATE494869T1 (de) 2005-12-28 2011-01-15 Procter & Gamble Absorbierende artikel mit elastischen komfortabelen laminaten
EP1958604A1 (en) 2007-02-13 2008-08-20 The Procter & Gamble Company Disposable absorbent articles with separate part

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5283173A (en) * 1990-01-24 1994-02-01 The Research Foundation Of State University Of New York System to detect protein-protein interactions
CA2128790A1 (en) * 1992-01-28 1993-08-05 Abraham Karpas Use of a compound for the manufacture of a medicament for the treatment of hiv infection
DK0665886T3 (da) * 1992-10-16 2003-10-06 Cold Spring Harbor Lab Omlejring af cyklinkomplekser og anvendelser, der er relateret dertil
DE69333969T2 (de) * 1992-10-30 2006-09-14 The General Hospital Corp., Boston Wechselwirkendes Fallensystem zur Isolierung von Proteinen

Also Published As

Publication number Publication date
FI970205A (fi) 1997-03-19
NO970258L (no) 1997-03-03
JPH11506301A (ja) 1999-06-08
WO1996003501A1 (en) 1996-02-08
FI970205A0 (fi) 1997-01-17
EP0775206A1 (en) 1997-05-28
AU2983295A (en) 1996-02-22

Similar Documents

Publication Publication Date Title
DE69516129T2 (de) Hybridfahrzeug
DE19581765T1 (de) Wagen-Verwaltungssystem
DE69429241T2 (de) Netzwerkunterstützungssystem
DE69634333D1 (de) Batterieladesystem
NO953605D0 (no) Kraftsystem
DE69527454D1 (de) Hybrid-Messaufnehmer
NO971007D0 (no) Vakuumsystem
DE69526961D1 (de) Fahrzeug
DE59707793D1 (de) Umrichtersystem
NO970258D0 (no) Dobbelt hybrid system
DE69509571D1 (de) Hohlraumangepasster Hybridkoppler
DE59501918D1 (de) Applikations-system
DE69514906D1 (de) Betätigungssystem
FI953885A0 (fi) Käyttökoneisto
DE9421723U1 (de) Parksystem
DE9420888U1 (de) Fahrzeug
DE69411598T2 (de) Betankungsanlage
DE29501574U1 (de) Lagersystem
FI940113A0 (fi) Aktiivinastajärjestelmä
DE9420029U1 (de) Fahrzeug
TR199501315A2 (tr) Valfli hibrit sisirici
SE9400294D0 (sv) System
ITRC940011V0 (it) Pancallo system
FIU940470U0 (fi) System foer gastryckstam
DE9407778U1 (de) Liegesystem